Expression of Bcl-2 Family Proteins in Thyrocytes from Young Patients with Immune and Nonimmune Thyroid Diseases

The Bcl-2 family proteins that control homeostasis of cells play an important role in apoptosis. This group consists of antiapoptotic (Bcl-2, Bcl-XL) and proapoptotic (Bcl-2 associated protein X, Bax; B-cell homologous antagonist/killer, Bak) molecules. In the thyroid, abnormal apoptotic activity may be involved in a variety of diseases such as autoimmune thyroid diseases. The aim of the current study was to estimate the expression of pro- and antiapoptotic proteins in thyroid tissues from young patients with Graves’ disease (GD), nontoxic nodular goiter and toxic nodular goiter using Western Blot and immunohistochemistry. Identification of the antiapoptotic Bcl-2 and Bcl-XL molecules in the thyrocytes revealed higher expression of both proteins in patients with GD (assessed as +++/++ and ++/+, respectively). In adolescents with toxic and nontoxic nodular goiter, this expression was lower (Bcl-2 ++/+ , ++/+; Bcl-XL +, +). The tissue material was additionally subjected to Western Blot analysis, which in GD patients showed the presence of Bcl-2 and Bcl-XL in one band p26 kDa. In patients with toxic and nontoxic nodular goiter, the intensity of expression for these two antiapoptotic proteins was lower (referred to band 26 kDa for Bcl-2 and Bcl-XL). Identification of the proapoptotic proteins Bax and Bak revealed their predominance in thyrocytes of GD patients (+, ++/+, respectively) as compared to patients with toxic and nontoxic nodular goiter (0/+, 0/+ for Bax and 0/+, 0/+ for Bak). In GD patients, Western Blot analysis showed Bax expression in one band 21 kDa and Bak in two bands p50, p24 kDa. In patients with nodular goiter, the degree of expression of both proapoptotic proteins was lower and referred to band 21 kDa for Bax (toxic and nontoxic goiter) and 24 kDa for Bak (toxic goiter only). Patients with GD showed a statistically significant correlation between Bcl-2 expression and antibodies against receptor for thyroid stimulating hormone (R = 0.47, p < 0.03); however, such a correlation was not observed in patients with nodular goiter. In conclusion, our findings suggest that the changes in the expression of regulatory proteins of the Bcl-2 family in the thyroid follicular cells indicate the involvement of apoptosis in the pathogenesis of GD.

[1]  B. Kalderon,et al.  Modulation of mitochondrial transition pore components by thyroid hormone. , 2005, Endocrinology.

[2]  S. Toda,et al.  Immunohistochemical analysis of bcl-2, Bax and Bak expression in thyroid glands from patients with Graves' disease. , 2004, Endocrine journal.

[3]  E. Mazzon,et al.  Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease. , 2004, The Journal of clinical endocrinology and metabolism.

[4]  K. Eguchi,et al.  Involvement of apoptotic cell death in autoimmune diseases , 2002, Medical Electron Microscopy.

[5]  G. Tsangaris,et al.  Fas and Bcl-2 protein expression in thyrocytes of patients with nodular goiter. , 2001, European journal of endocrinology.

[6]  M. Hengartner The biochemistry of apoptosis , 2000, Nature.

[7]  R. Mirakian,et al.  Death of the autoimmune thyrocyte: is it pushed or does it jump? , 2000, Thyroid : official journal of the American Thyroid Association.

[8]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[9]  P. Fonlupt,et al.  Susceptibility of Differentiated Thyrocytes in Primary Culture to Undergo Apoptosis after Exposure to Hydrogen Peroxide: Relation with the Level of Expression of Apoptosis Regulatory Proteins, Bcl-2 and Bax. , 1999, Endocrinology.

[10]  E. Brambilla,et al.  Graves-Basedow disease goiter: a model of Bax-Bcl2 regulated apoptosis. , 1999, Thyroid : official journal of the American Thyroid Association.

[11]  S. Korsmeyer,et al.  Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.

[12]  R. Mirakian,et al.  IL‐10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? , 1998, Clinical and experimental immunology.

[13]  Yuanming Hu,et al.  Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  V. Dixit,et al.  Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex* , 1998, The Journal of Biological Chemistry.

[15]  M. Sospedra,et al.  Single‐cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease , 1997, European journal of immunology.

[16]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[17]  G. Kroemer The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.

[18]  John Calvin Reed Double identity for proteins of the Bcl-2 family , 1997, Nature.

[19]  A. Goode,et al.  ANALYSIS OF APOPTOSIS IN RELATION TO TISSUE DESTRUCTION ASSOCIATED WITH HASHIMOTO'S AUTOIMMUNE THYROIDITIS , 1997, The Journal of pathology.

[20]  S. Cory,et al.  Life-or-death decisions by the Bcl-2 protein family. , 2001, Trends in biochemical sciences.